Abstract
COMMUNICATION FRAMEWORK IN THE PHARMACOVIGILANCE PROGRAMME OF INDIA (PvPI)
Pritam Maurya, Pranjal Yadav, Prem Prakash Mishra, Naincy Singh, Krishnanand Prajapati
Nirmala Devi Pharmacy College, Jaunpur, U.P, India.
Abstract
In order to ensure drug safety, pharmacovigilance is crucial for identifying, evaluating, and preventing adverse drug reactions (ADRs). A well-organized communication framework is essential to the Pharmacovigilance Programme of India (PvPI), which is the country's mechanism for monitoring medication safety. The organizational structure, ADR reporting methods, data management procedures, and feedback mechanisms within PvPI are highlighted in this evaluation, with a focus on the contribution of digital platforms like VigiFlow, mobile applications, and helpline services to enhancing reporting accessibility and efficiency. It also talks about how important stakeholders, like as patients, regulators, and medical professionals, can help to improve pharmacovigilance procedures. Even with significant progress, problems including underreporting, low awareness, and technological obstacles still exist. The system's performance is being improved by recent advancements including digital transformation, worldwide integration, and the application of advanced analytics. In general, improved ADR reporting, regulatory decision-making, and patient safety results in India all depend heavily on effective communication.
Keyword: Pharmacovigilance, PvPI, adverse drug reactions, communication framework, drug safety, signal detection, India
Article Information
| Article Type |
Review Article |
| Journal Name |
Global Journal of Pharmaceutical and Scientific Research
|
| ISSN |
3108-0103 |
| Volume |
Volume-2 |
| Issue |
Issue-4, April-2026 |
| Corresponding Author |
Pritam Maurya, Pranjal Yadav, Prem Prakash Mishra, Naincy Singh, Krishnanand Prajapati |
| Address |
Nirmala Devi Pharmacy College, Jaunpur, U.P, India. |
| Received |
22 Mar, 2026 |
| Revised |
31 Mar, 2026 |
| Accepted |
13 Apr, 2026 |
| Published |
23 Apr, 2026 |
| Pages |
615-638 |